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against smooth muscle alpha actin. Capillary endothelial cells (stained with
an antibody against von Willebrand factor, vWF) showed only weak colocal-
ization with bFGF so that the relationship between the morphometric area
fractions of vWF and bFGF was even inverse (R = -0.662, p = 0.0005). Sim-
ilarly to bFGF, intense immunolabeling of platelet derived growth factors AA
and SS (PDGFs) was observed on vascular smooth muscle cells, whereas its
correlation with the vWF-staining of capillary endothelial cells was inverse (R
= -0.387, p < 0.025). PDGFs were not detected in the extracellular ma-
trix. In contrast to bFGF and PDGFs, transforming growth factor-,8 (TGF-,8)
was primarily associated with vWF-positive capillary endothelial cells. The
extracellular matrix contained TGF-,8 in areas of scarring and repair. Conclu-
sion: In the failing myocardium, TGF,8 is primarily expressed on the capillary
endothelium, wheras PDGFs and bFGF are more associated with the vas-
cular smooth muscle cells of intramural coronary arteries. In addition, large
amounts of bFGF are bound to collagen type 1. These distinct patterns of
distribution of growth factors suggest a network of feedback mechanisms
involving different cell types and the extracellular matrix during ventricular
remodeling.
~ Syncope and Sudden Cardiac Death: Clinical
Predictors, Tilt Testing, and Electrophysiologic
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1719-1 I Does Vasodepressor Syncope Require Normal
Ventricular Function?
Andrea Natale, Jasbir Sra, Anwer Dhala, Michael Biehl, Abdul Wase,
Sanjay Deshpande, Cheryl Maglio, Margaret Budziszewski, Masood Akhtar. SInai
Samaritan/St. Luke's Medical Center, Milwaukee, WI
Vasodepressor syncope is believed to be preceded by hypercontractility
which leads to mechanoreceptor stimulation. Therefore, a preserved left ven-
tricular function is supposedly required to trigger the reflex. We analyzed our
experience in patients with positive head-up tilt test. Out of 500 patients 32
had previous history of structural heart disease. Of them 8 patients had se-
vere left ventricular dysfunction (EF < 30%). The mean age was 52 ± 8 years,
5 were male and 3 female. Mean EF was 22 ± 5%. Six patients had dilated
cardiomyopathy and 2 had myocardial infarction. Electrophysiologic study
was negative in 6 patients while the remaining two had inducible sustained
monomorphic ventricular tachycardia requiring defibrillator implant. Syncope
was witnessed by physicians in 6 out of 8 patients and was associated with
bradycardia and hypotension. In all8 patients head-up tilt reproduced symp-
toms. Upright tilt was positive at baseline in 7 patients and during isopro-
terenol infusion in 1 patient. Five patients were treated with theophylline, 1
with ephedrine, and 2 with disopyramide. After a mean follow-up of 2.2 ±
1.3 years all 8 patients were free of vasodepressor-related syncope.
Conclusion: We conclude that vasodepressor syncope is possible even
in the presence of severely impaired ventricular function and should, there-
fore, be entertained in such cases. Alternative mechanisms may mediate the
circulatory response in this population.
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1719-21 Evolution of Patients with Neurocardiogenic
(Vasovagal) Syncope not Subjected to a Specific
Treatment
Aurora Ruiz, Adelqui Peralta, Eleonora Duce, Jorge Scaglione,
Jorge Gonzalez-Zuelgaray. Argerich Hospital, Buenos Aires, Argentina
The results obtained with some drugs or other therapeutic strategies in the
prevention of neurocardiogenic syncope are encouraging. However, the ben-
efit they represent when compared with the natural history of this disorder
has not been clearly established. The purpose of this prospective study was
to analyze the natural history of patients with neurocardiogenic syncope.
Fifty-six consecutive patients with either: a) One or more episodes of syn-
cope and a positive head-up Tilt test (29 patients), or b) Typical history of
neurocardiogenic (vasovagal) syncope (27 patients) despite a negative Tilt
test, were followed up by telephone or personal consultation during a mean
period of 16.1 ± 10.2 months. Patients were discharged without any specific
medication.
There were no deaths during the follow-up period. Recurrences were
found in 5 patients (8.9%). The risk of recurrence was 7% after one year
and 15% after 21 months. The multivariate analysis showed the duration of
symptoms before the inclusion as an independent variable related to recur-
rences (p < 0.025).
Conclusions: The prognosis of patients with neurocardiogenic syncope is
excellent as far as survival is concerned. Recurrences of episodes without
any specific treatment are uncommon after diagnosis has taken place. This
finding strengthens the need to evaluate the effect of drugs with placebo
control groups and to select the highest risk group for treatment.
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Usefulness of Signal-Averaged ECG, Head-up Tilt
and Eleetrophysiologic Studies in Patients with
Unexplained Syncope
Carlos A. Morillo, Sally Zandri, George J. Klein, Raymond Vee. McGuire VA Medical
Center, Richmond, VA: University Hospital, London, Ontario, Canada
The recent availability of non-invasive diagnostic methods such as signal-
averaged ECG (SAECG) and Head-up tilt (HUT) have raised the need to evalu-
ate the role of such tests for the screening of pts with recurrent unexplained
syncope (US). The purpose of the present study was to identify the clini-
cal variables that predicted an abnormal SAECG and HUT in a series of 70
consecutive pts. referred for assessment of recurrent US. SAECG (ART EPX
1200) and HUT @ 60° with a low-dose isoproterenol protocol for 30 minutes,
were performed in all pts. SAECG was considered (+) if ?;2 of Simson crite-
ria were abnormal. A (+) HUT was defined as the induction of presyncope or
syncope associated with bradycardia and hypotension that resembled the
clinical episode. All pts underwent 2D-echo, radionuclide angiography and
electrophysiologic study (EPS).
VT(+) SAECG(+) SAECG(-) HUl(+) HUll-) EPS
N Pts 24 (34%) 46 (64%) 30(42%) 40 (57%) 29{41%)
AGE 42 ± 12 45 ± 16 36 ± 10' 55 ± 10' 45 ± 15
EF% 34 ± 8' 53 ± 6 55 ± 9 53 ± 5 36 ± 5'
PMI 16(67%)' 4(9%) 2(6.6%) 2(5%) 19 (66%)'
EF = Eyection fraction. PMI = Previous myocardial infarction. * = MultivariabJe analysis
p<OO1
A (+) SAECG, previous MI and EF < 40% were highly predictive (95%) of
induction of sustained monomorphic VT during EPS. Similarly, (-) SAECG
and age < 50 yrs were associated with a (+) HUT in 96%. Overall a cause
for US was determined in 77%.
Conclusions: A (+) SAECG, EF < 40% and history of a previous MI were
highly predictive of the induction of VT during EPS in pts with US. A (-)
SAECG, EF > 40% and age> 50 yrs were predictive of a (+) HUT. Non-
invasive screening of pts with US with SAECG and HUT increased the di-
agnostic yield and should be performed prior to invasive assessment with
EPS.
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1719-41 RR Variability Preceding Head Up Tilt Predicts
Syncope in Children
Julian M. Stewart, Markus Erb, David Rubin, Carmine Sorbera. New York Medical
College, Valhalla, NY
To assess RR variability during head up tilt (HUT) we studied 20 syncopal pts
aged 7-18y with Holter monitor. After 30 min supine, pts were tilted to 80°
for 30 min or until syncope occurred. Sequential 256 and 512 beat epochs
free from ectopy were analyzed. Mean and standard deviation, root mean
square (RMSSD), fraction exceeding 50 msec (pN50) and correlation coeffi-
cient (r) of successive differences were computed. An autoregressive power
spectrum model was used. Low frequency power (LFP. 0.05-0.15 Hz). high
frequency power (HFP. 0.15-040 Hz), and total power (TP. 0.01-0.40 Hz) were
compared. Epochs while supine, within 5 minutes after HUT, 5--10 min after
HUT, and 15 min after or during syncope were analyzed. 12 pts fainted (F)
and B did not (N). RR interval was 910 ± 6 for Nand 870 ± 4 msec for F
(p = NS). Indices of RR variability were markedly different (p < 0.05) for F
and N while supine: RMSSD was 128 ± 22 for N vs 62 ± 7 msec for F. pN50
was 0.51 ± 0.06 for N vs 0.33 ± 0.04 for F, r was 0.50 ± 0.06 for N vs 0.70
± 0.05 for F. LFP was 920 ± 140 in N vs 1710 ± 440 msec2 in F (p = NS),
while HFP and TP were 2990 ± 840 and 7062 ± 1500 in N vs 834 ± 130
and 2855 ± 420 msec2 in F (p < 0.05). With HUT RR decreased similarly in
F and N (25 ± 3% and 26 ± 3%) while RMSSD and pN50 decreased pro-
portionately in N (by 59 ± 5% and 63 ± 10%) and in F (by 59 ± 4% and
83 ± 5%, p = NS). RMSSD and pN50 remained higher in N vs F after tilt. r
increased for N (to 0.77 ± 0.05) and F (to 0.88 ± 0.02) but remained higher
in F reflecting lower variability. LFP. HFP. and TP decreased proportionately
for each group. Thus HFP and TP remained higher in N than F. Similar results
were obtained after 5--10 minutes of HUT in Nand F and after 15 minutes in
N. In F prior to syncope, RR increased to 1,045 ± 50 msec, RMSSD to 125 ±
25 msec, PN50 to 0.41 ± 0.05, and r fell to 0.51 ± 0.04, while TP increased
to 5200 ± 1343 msec2, LFP increased to 1717 ± 601 msec2, and HFP in-
creased to 2730 ± 1075 msec2. Relatively decreased RR variability supine
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prior to HUT predicts syncope and is primarily caused by decreased high
frequency power.
Clinical StUdies of PTCA
Bernard Chevalier, Bernard Lancelin, Xavier Berthaux. C.C. Marie Lannelongue, Le
Plessis-Robinson, France
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Hemostatic Puncture Closure Device Versus
RegUlar Compression: A Randomized Study
Compression time (min ,j
Hemostasis delay (min.)
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Ambulation delay (hr.)
Minor local event (%)
(=hematoma and/or rebleeding or small AVfistula)
We noted no major local event (false aneurysm, transfusion, surgical re-
pairl in both groups. In HPCD group, ultrasonography showed the resorbable
anchor in 96% which was correctly flushed against arterial wall in 94%.
Thus, HPCD use allows a dramatic decrease in compression and pressure
dressing time, an earlier ambulation and a significant reduction in minor local
complication.
Monday, March 20, 1995, 3:00 p.m.-5:00 p.m.
Ernest N. Morial Convention Center, Hall E
Presentation Hour: 3:00 p.m.-4:00 p.m.
In order to assess the efficacy of a new hemostatic puncture closure de-
vice (HPCD)(Angioseal*). 100 patients who underwent coronary angiography
(75) or coronary angioplasty (25). using femoral approach, were randomized
between HPCD placement (N = 52) or regular compression (C) (manual or
mechanical pressure then pressure dressing) (N = 48). Clinical data, antico-
agulation regimen, sheath size, delay of sheath removal, aPTT at the removal
were not statistically different in both groups. Pts were randomized imme-
diately before the sheath removal. A serial clinical follow-up was done until
24 hours and a systematic vascular ultrasonography (with pulsed and color
doppler examination) was performed before hospital discharge. In the HPCD
group, device placement was successful in all but one. Hemostasis was im-
mediate in 67%; in 8 pts (15%) a light manual pressure was necessary (15
± 10 min.) to stop the bleeding. Results in the two groups were:
Limitations of Percutaneous Interventions in the
Treatment of Bifurcation Lesions Involving the
Left Anterior Descending Coronary Artery
3:00
Clinical Correlates and Prognostic Significance of the
Frequency of Episodes of Nonsustalned Ventricular
Tachycardia in the Electrophysiologic Study versus
Electrocardiographic Monitoring Trial (ESVEM)
Kelley P. Anderson. Motomi Mori, ESVEM Investigators. University ofPittsburgh,
Pittsburgh, PA
Nonsustained ventricular tachycardia (VTns) predicts mortality in several set-
tings but its significance in patients (pts) with a history of sustained ventric-
ular tachyarrhythmias is unknown. Pts in ESVEM were randomized to guid-
ance method and to drug independent of VTns events. We grouped pts (n
= 486) by frequency of VTns events on baseline 48hr drug-free HM: Gl ==
No VTns (n = 70). G2 == >0 to <0.25 runs/h (n = 190). G3 == ~0.25 to <1
runs/h (n = 109), G4 == ~1 runs/h (n = 117). There were no significant differ-
ences (p > 0.05) between groups with respect to age, ejection fraction, func-
tional class, presenting arrhythmia, prior exposure to antiarrhythmic drugs
or guidance method. Data are presented in order of group number (Grl, 2,
3, 4, respectively). Significant differences were observed for sex (29, 8, 13,
15 %female; p = 0.0008), previous myocardial infarction (6%, 10%, 22%,
23%; p = 0.0002). PVC/h (136,146,300,735; p < 0.0001), pairs/h (1, 3,12,
60; p < 0.0001), and mean heart rate (77, 74, 74, 80 bpm; p = 0.0008). Be-
cause the significance of VTns may vary in pts with different disorders, an
analysis was restricted to pts with ischemic heart disease (IHD, n = 414).
Significant differences were observed for age (63, 65, 64, 67 yr; p = 0.01).
sex (23, 6, 10,9 %female, p = 0.0028). years since last myocardial infarction
(MI) (3.7,8.9,9.1, 7.9yr; p < 0.0001), history of operative revascularization
(8%,29%, 30%, 38%; p = 0.0003), for PVC/h (151, 149,286, 769 PVC/h; p
< 0.0001). mean pairs/h (1, 3, 12,62; P < 0.0001). mean heart rate (76, 74,
76, 81 bpm; p = 0.004), but not for ejection fraction, functional class, pre-
senting arrhythmia, previous exposure to antiarrhythmic drugs, number of
Mis, or angina since last MI. Variables based on presence/absence, on con-
tinuous and on stratified frequency measures of VTns events and the above
variables were entered into a Cox proportional hazards regression model for:
1) pts discharged on a drug predicted to be effective, 2) all randomized pts
(intention-to-treat). 3) pts with IHD. None of the VTns variables were signifi-
cant independent predictors of arrhythmia recurrence or all-cause mortality.
We conclude that significant clinical differences exist between groups of pts
with different frequencies of VTns events. However, measures of VTns event
frequency were not predictors of arrhythmia recurrence or mortality in this
group of patients with known ventricular tachyarrhythmias.
Conclusion: LAD bifurcation lesion intervention is associated with a high
in-hospital complication rate. Since these lesions are not amenable to stent
placement or atherectomy with simultaneous protection of both vessels,
these cases should be carefully evaluated before intervention, and bypass
surgery should be considered as a treatment option.
Brian A. Armstrong, Jean-Frangois Tanguay, Kevin R. Kruse, James P. Zidar, Michael
H. Sketch, Jr., Robert H. Peter, Harry R. Phillips, James E. Tcheng, Richard S. Stack.
Duke University, Durham, NC
Serious complications may occur when intervention is unsuccessful in bi-
furcation lesions involving the left anterior descending (LAD) and first major
diagonal (D). because of the large amount of involved myocardium. To deter-
mine this complication rate, we reviewed 82 consecutive cases, over a 3 year
period, in which these lesions were attempted. Sixty-six percent of the sub-
jects were male, and 37% had unstable angina. The mean age was 59 and
the mean ejection fraction was 56%. Digital calipers were used to measure
vessel minimum lumen (MLD) and reference diameters. For the LAD the final
MLD was 1.81 mm and for the 0 1.32 mm. The final percent mean diameter
stenoses for the LAD and D were 41 % and 45%, respectively. There were
no significant differences in the rates of success or complication between
groups treated with angioplasty only (N = 68) or directional atherectomy (N
= 14). The in-hospital event-free success rate was 55%. The in-hospital com-
plication rates were:
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1719-61 Right Bundle Branch Block, ST Segment Elevation
and Sudden Cardiac Death. Symptomatic,
Asymptomatic and Intermittent Forms
Josep Brugada, Pedro Brugada 1. Hospital Clinic, University of Barcelona, Spain;
Cardiovascular Center, Aalst. Belgium
Objectives: We recently described a syndrome characterized by an electro-
cardiographic (ECG) pattern of right bundle branch block and persistent ST
segment elevation in leads Vl to V3 in 8 patients (pts) suffering from aborted
sudden death without structural heart disease. The objectives of the present
study are to present new observations on this syndrome.
Methods: A total of 22 pts (mean age 40 ± 12 years) have been identified
with the described ECG pattern. Of them, 17 were symptomatic with syn-
cope and aborted sudden cardiac death. The other 5 pts were asymptomatic
when first seen, however, 1 died suddenly after 6 years of follow-up without
treatment and another received an implantable defibrillator after syncope.
Subsequently, several episodes of ventricular fibrillation were terminated by
the defibrillator in this pt. The other 3 pts remain asymptomatic without treat-
ment. In 4 of 22 pts the ECG transiently normalized during follow-up.
Conclusions: The present observations demonstrate that there exist
asymptomatic pts with this syndrome. These pts may become symptomatic
during follow-up. It is difficult to set a therapeutic strategy for these asymp-
tomatic pts at present. Our observations also show that the ECG can tran-
siently normalize, suggesting that the disease is not based on a permanent
structural cardiac abnormality, but rather on functional alterations olthe elec-
trical activity of the heart.
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